Zydus has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its manufacturing facility located at Pharmez, Ahmedabad from March 20 to 24, 2023, the company announced on Mo0nday through an exchange filing.
The inspection has been classified as Voluntary Action Indicated (VAI). The EIR report indicates that the inspection is closed.
Zydus Shares
The shares of Zydus on Monday at 11:18 am IST were at Rs 590.85, up by 1.34 percent.
(To receive our E-paper on WhatsApp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)
